Coeptis Therapeutics, Inc. Convertible Debt
Coeptis Therapeutics, Inc. had Convertible Debt of $3.90 million as of 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2022-11-08
- 2022-09-30: Convertible Debt $3.90M.
- 2022-06-30: Convertible Debt $3.90M.
| Period end | Convertible Debt |
|---|---|
| 2022-09-30 | $3.90M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.90M 10-Q · filed 2022-08-02 |